Vittoria Cioce

Title: Vittoria Cioce: Innovator in Hepatocyte Growth Factor Research

Introduction

Vittoria Cioce is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of biotechnology, particularly in the area of hepatocyte growth factor (HGF) research. Her innovative work has led to the development of novel therapeutic approaches.

Latest Patents

Vittoria Cioce holds a patent for a truncated hepatocyte growth factor variant protein, specifically HGF/NK2. This invention relates to a novel truncated form of HGF that specifically antagonizes the activity of HGF. It also includes a truncated form of HGF that acts as a partial agonist. The patent details the purification, molecular cloning, and recombinant expression of these truncated HGF variants, along with related pharmaceutical compositions. Furthermore, it discusses the utilization of these small HGF variants to either inhibit or stimulate HGF mitogenesis in cells expressing the HGF receptor.

Career Highlights

Cioce is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her work at this esteemed institution has allowed her to explore groundbreaking research in the field of growth factors and their implications in health and disease.

Collaborations

Some of her notable coworkers include Andrew M. L. Chan and Jeffrey S. Rubin. Their collaborative efforts have contributed to advancing the understanding of HGF and its potential therapeutic applications.

Conclusion

Vittoria Cioce's innovative research and patent contributions in the field of hepatocyte growth factor highlight her role as a leading inventor in biotechnology. Her work continues to pave the way for new therapeutic strategies in medicine.